545 related articles for article (PubMed ID: 21661727)
1. Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy.
Tassa C; Shaw SY; Weissleder R
Acc Chem Res; 2011 Oct; 44(10):842-52. PubMed ID: 21661727
[TBL] [Abstract][Full Text] [Related]
2. Surface engineering of iron oxide nanoparticles for targeted cancer therapy.
Kievit FM; Zhang M
Acc Chem Res; 2011 Oct; 44(10):853-62. PubMed ID: 21528865
[TBL] [Abstract][Full Text] [Related]
3. 18F labeled nanoparticles for in vivo PET-CT imaging.
Devaraj NK; Keliher EJ; Thurber GM; Nahrendorf M; Weissleder R
Bioconjug Chem; 2009 Feb; 20(2):397-401. PubMed ID: 19138113
[TBL] [Abstract][Full Text] [Related]
4. Nucleophilic cross-linked, dextran coated iron oxide nanoparticles as basis for molecular imaging: synthesis, characterization, visualization and comparison with previous product.
Borny R; Lechleitner T; Schmiedinger T; Hermann M; Tessadri R; Redhammer G; Neumüller J; Kerjaschki D; Berzaczy G; Erman G; Popovic M; Lammer J; Funovics M
Contrast Media Mol Imaging; 2015; 10(1):18-27. PubMed ID: 24753451
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 64Cu-labeled magnetic nanoparticles for multimodal imaging.
Jarrett BR; Gustafsson B; Kukis DL; Louie AY
Bioconjug Chem; 2008 Jul; 19(7):1496-504. PubMed ID: 18578485
[TBL] [Abstract][Full Text] [Related]
6. (⁹⁹m)Tc-bisphosphonate-iron oxide nanoparticle conjugates for dual-modality biomedical imaging.
Torres Martin de Rosales R; Tavaré R; Glaria A; Varma G; Protti A; Blower PJ
Bioconjug Chem; 2011 Mar; 22(3):455-65. PubMed ID: 21338098
[TBL] [Abstract][Full Text] [Related]
7. Dextran-Benzoporphyrin Derivative (BPD) Coated Superparamagnetic Iron Oxide Nanoparticle (SPION) Micelles for T
Yan L; Luo L; Amirshaghaghi A; Miller J; Meng C; You T; Busch TM; Tsourkas A; Cheng Z
Bioconjug Chem; 2019 Nov; 30(11):2974-2981. PubMed ID: 31661959
[TBL] [Abstract][Full Text] [Related]
8. Nonpolymeric surface-coated iron oxide nanoparticles for in vivo molecular imaging: biodegradation, biocompatibility, and multiplatform.
Lee CM; Cheong SJ; Kim EM; Lim ST; Jeong YY; Sohn MH; Jeong HJ
J Nucl Med; 2013 Nov; 54(11):1974-80. PubMed ID: 24050935
[TBL] [Abstract][Full Text] [Related]
9. Redox-responsive dextran based theranostic nanoparticles for near-infrared/magnetic resonance imaging and magnetically targeted photodynamic therapy.
Ding Z; Liu P; Hu D; Sheng Z; Yi H; Gao G; Wu Y; Zhang P; Ling S; Cai L
Biomater Sci; 2017 Mar; 5(4):762-771. PubMed ID: 28256661
[TBL] [Abstract][Full Text] [Related]
10. Identification of molecular-mimicry-based ligands for cholera diagnostics using magnetic relaxation.
Kaittanis C; Banerjee T; Santra S; Santiesteban OJ; Teter K; Perez JM
Bioconjug Chem; 2011 Feb; 22(2):307-14. PubMed ID: 21226491
[TBL] [Abstract][Full Text] [Related]
11. Superparamagnetic iron oxide nanoparticles: amplifying ROS stress to improve anticancer drug efficacy.
Huang G; Chen H; Dong Y; Luo X; Yu H; Moore Z; Bey EA; Boothman DA; Gao J
Theranostics; 2013; 3(2):116-26. PubMed ID: 23423156
[TBL] [Abstract][Full Text] [Related]
12. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics.
Nguyen KT; Zhao Y
Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438
[TBL] [Abstract][Full Text] [Related]
13. Construction of iron oxide nanoparticle-based hybrid platforms for tumor imaging and therapy.
Hu Y; Mignani S; Majoral JP; Shen M; Shi X
Chem Soc Rev; 2018 Mar; 47(5):1874-1900. PubMed ID: 29376542
[TBL] [Abstract][Full Text] [Related]
14. Conquering the dark side: colloidal iron oxide nanoparticles.
Senpan A; Caruthers SD; Rhee I; Mauro NA; Pan D; Hu G; Scott MJ; Fuhrhop RW; Gaffney PJ; Wickline SA; Lanza GM
ACS Nano; 2009 Dec; 3(12):3917-26. PubMed ID: 19908850
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of dextran stabilized superparamagnetic iron oxide nanoparticles for in vivo MR imaging of liver fibrosis.
Saraswathy A; Nazeer SS; Nimi N; Arumugam S; Shenoy SJ; Jayasree RS
Carbohydr Polym; 2014 Jan; 101():760-8. PubMed ID: 24299836
[TBL] [Abstract][Full Text] [Related]
16. Rapid size-controlled synthesis of dextran-coated, 64Cu-doped iron oxide nanoparticles.
Wong RM; Gilbert DA; Liu K; Louie AY
ACS Nano; 2012 Apr; 6(4):3461-7. PubMed ID: 22417124
[TBL] [Abstract][Full Text] [Related]
17. Chemical synthesis and assembly of uniformly sized iron oxide nanoparticles for medical applications.
Ling D; Lee N; Hyeon T
Acc Chem Res; 2015 May; 48(5):1276-85. PubMed ID: 25922976
[TBL] [Abstract][Full Text] [Related]
18. Iron oxide nanoparticles for targeted cancer imaging and diagnostics.
Rosen JE; Chan L; Shieh DB; Gu FX
Nanomedicine; 2012 Apr; 8(3):275-90. PubMed ID: 21930108
[TBL] [Abstract][Full Text] [Related]
19. Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications.
Dadfar SM; Roemhild K; Drude NI; von Stillfried S; Knüchel R; Kiessling F; Lammers T
Adv Drug Deliv Rev; 2019 Jan; 138():302-325. PubMed ID: 30639256
[TBL] [Abstract][Full Text] [Related]
20. On the use of superparamagnetic hydroxyapatite nanoparticles as an agent for magnetic and nuclear in vivo imaging.
Adamiano A; Iafisco M; Sandri M; Basini M; Arosio P; Canu T; Sitia G; Esposito A; Iannotti V; Ausanio G; Fragogeorgi E; Rouchota M; Loudos G; Lascialfari A; Tampieri A
Acta Biomater; 2018 Jun; 73():458-469. PubMed ID: 29689381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]